Microdosing psychedelics, typically lysergic acid diethylamide (LSD) or psilocybin, has recently gathered attention for its potential to improve mental health. Although self-reported benefits include heightened creativity, mood enhancement, and reduced symptoms of depression, scientific evidence remains limited.
Nevertheless, anecdotal evidence strongly suggests low doses may support cognitive flexibility and mindfulness, thereby alleviating rumination. However, most findings come from small-scale or observational studies, with many confounding factors, such as expectancy effects, making it difficult to draw definitive conclusions. 1
While early research on single low-dose LSD or psilocybin shows minimal adverse physiological effects, increases in anxiety and mood fluctuations have also been reported. Tolerance may develop quickly, suggesting that careful scheduling is crucial for sustained benefits. Crucially, large-scale, placebo-controlled trials are still needed to determine efficacy , safety, and overall long-term impact on depressive symptoms. 1
This article explores the science behind microdosing psychedelics, its potential mental health benefits, risks, and the ongoing research to determine its therapeutic value. Microdosing Mushrooms. Image Credit: Losangela/Shutterstock.com Mechanism of action
Low doses of psychedelics like LSD and psilocybin primarily act through the brain’s serotonin system, notably by binding to 5-Hydroxytryptamine 2A (5-HT2A) receptors on neurons in key regions such as the prefrontal cortex and hippocampus.
As partial agonists, these substances subtly modulate both excitatory (glutamatergic) and inhibitory (GABAergic) neural signaling. In other words, they can nudge the balance of neuronal activity without triggering the pronounced perceptual alterations typical of higher doses. 2
By engaging 5-HT2A receptors, low-dose psychedelics promote moderate changes in cellular signaling pathways, including those involving intracellular calcium and the release of neurotransmitters.
This can result in a mild increase in neuroplasticity , essentially making it easier for neurons to reorganize and form new connections. These small shifts in connectivity patterns are thought to facilitate flexible thinking, creativity, and stress resilience. 2
Moreover, these compounds gently affect the default-mode network (DMN), a brain system active during self-reflective thought and mind-wandering. Under low-dose conditions, psychedelics may reduce the DMN’s rigid activity, loosening habitual rumination without causing the full “ego-dissolution” reported at higher doses.Altogether, these mechanisms underlie the mood, cognition, and creativity benefits attributed to psychedelic […]
Get Creative with Cannabis: The Ultimate Guide to Painting and Pottery Workshops
Creative with Cannabis Cannabis and creativity go hand in hand—especially
